| Completed | The Effects of Nutritional Intervention on Health Parameters in Participants With Type 2 Diabetes Mellitus NCT06235762 | Sao Jose do Rio Preto Medical School | N/A |
| Completed | A Pilot Study on Effect of SKY on Psychosocial Parameters of Type 2 Diabetic Patients After a 6 Days NCT02661906 | Dasman Diabetes Institute | N/A |
| Completed | Assessment of Insulin Sensitivity and β Cell Function by Clamps Studies NCT02662400 | Post Graduate Institute of Medical Education and Research, Chandigarh | Phase 2 / Phase 3 |
| Suspended | Effects of Low Power Laser Therapy on Muscle Performance Isokinetic Pre-exercise in Individuals With Diabetes NCT01925443 | University of Nove de Julho | N/A |
| Completed | Clinical Trial With Broccoli Sprout Extract to Patients With Type 2 Diabetes NCT02801448 | Anders Rosengren, MD PhD | Phase 2 |
| Completed | Effect of Gelofusine on GLP1-receptor Imaging NCT02541734 | Radboud University Medical Center | Phase 1 / Phase 2 |
| Completed | Saxagliptin and Cardiac Structure and Function NCT02481479 | Unity Health Toronto | Phase 4 |
| Completed | Translating Healthy Lifestyle Interventions for Cancer Survivors NCT02690766 | University of North Carolina, Chapel Hill | N/A |
| Completed | To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study NCT02299388 | Tulane University School of Medicine | Phase 4 |
| Completed | Tablet-Aided BehavioraL Intervention EffecT on Self-management Skills NCT02128854 | Medical University of South Carolina | N/A |
| Completed | Making Ramadhan Fasting a Safer Experience With Technology Study NCT02189135 | Monash University | Phase 4 |
| Unknown | Nurse-led Reminder Program for Therapy Adherence, Clinical Outcomes and Trust in Nurses in Diabetic Patients NCT02196272 | Azienda Sanitaria Locale n. 2 - Lanciano Vasto Chieti | N/A |
| Completed | Evaluation of Advanced Glycation End-products (AGE) and the Erectile Dysfunction (DE) in Diabetic Patients NCT02770235 | Centre Hospitalier Universitaire, Amiens | N/A |
| Unknown | Effect of Laparoscopic Roux-en-Y Gastric Bypass Surgery on Non-severe Obesity With Type 2 Diabetes Mellitus NCT02091323 | Guangzhou General Hospital of Guangzhou Military Command | N/A |
| Completed | PK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester E NCT02113163 | Thetis Pharmaceuticals LLC | Phase 1 |
| Completed | Technology Intensified Diabetes Education Study in African Americans NCT02088658 | State University of New York at Buffalo | N/A |
| Completed | Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events NCT01730534 | AstraZeneca | Phase 3 |
| Completed | Effects of Vildagliptine and Glimepiride on Glucose Variability NCT01812122 | Seoul National University Hospital | Phase 4 |
| Completed | The Efficacy and Safety Study in Patients With Type 2 Diabetes Mellitus NCT01608724 | AstraZeneca | Phase 4 |
| Completed | OPtimal Type 2 dIabetes Management Including Benchmarking and Standard Treatment in CEEMEA NCT01694758 | AstraZeneca | — |
| Completed | Point of Service Diabetes Screening Evaluation NCT01669616 | VeraLight, Inc. | — |
| Completed | Evaluation of SCOUT DS in Subjects With Type 2 Diabetes #2 NCT01346046 | VeraLight, Inc. | — |
| Completed | Tissue Distribution of F18-FDG Labeled ABMSCT in Patients With Type2 Diabetes Mellitus NCT02585505 | Post Graduate Institute of Medical Education and Research, Chandigarh | Phase 1 / Phase 2 |
| Withdrawn | Effect of Lycopene and Isoflavones on Glucose Metabolism NCT01377961 | The University of Texas Medical Branch, Galveston | N/A |
| Completed | Single Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes NCT01105429 | Bristol-Myers Squibb | Phase 1 |
| Completed | Effects of Exercise Intervention and Rehabilitation Exercise Intervention in Patients With Type 2 Diabetes NCT01393275 | University of Giessen | N/A |
| Completed | Safety Study of BMS-816336 in Healthy Male Subjects NCT00979368 | Bristol-Myers Squibb | Phase 1 |
| Completed | MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus NCT00837577 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Zinc Supplementation in Type 2 Diabetics NCT01309620 | National University Hospital, Singapore | Phase 2 / Phase 3 |
| Terminated | The Effect of Sitagliptin in Type 2 Diabetes Mellitus With Inadequate Glycemic Control (MK0431-118) NCT00832624 | Merck Sharp & Dohme LLC | Phase 4 |
| Completed | MK-1006 Single Dose Study in Japanese Type 2 Diabetes Patients (MK-1006-005) NCT00791661 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | MK-0941 Multiple Dose Study in Japanese Patients With Type 2 Diabetes (MK-0941-011). NCT00754130 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | Telephone Delivered Behavioral Skills Intervention for Blacks With T2DM NCT00929838 | State University of New York at Buffalo | N/A |
| Completed | A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabete NCT00701090 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | An Efficacy, Safety, and Tolerability Study of Canagliflozin (JNJ-28431754) in Patients With Type 2 Diabetes NCT00642278 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 2 |
| Completed | An Open-Label, Single- & Multiple-Dose Study to Investigate the Pharmacokinetics of Sitagliptin 100 mg in Heal NCT00642798 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets NCT00550329 | Pfizer | — |
| Completed | Addition Of Januvia (Sitagliptin) Improves Glycemic Control In Patients Inadequately Controlled By Metformin ( NCT00545584 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Study to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With Type 2 Diabetes M NCT00875394 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | A Study of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/ NCT00411554 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Impact of Type 2 Diabetes Peer Counseling on Behavioral, Metabolic, and Health Outcomes Among Latinos NCT01299844 | University of Connecticut | N/A |
| Completed | Cardiovascular Risk Factor Management in HIV Infection NCT00264394 | University Hospital, Basel, Switzerland | Phase 4 |
| Completed | A Trial to Study the Effect of Vitamin D Supplementation on Glucose and Insulin Metabolism in Centrally Obese NCT00347542 | Sitaram Bhartia Institute of Science and Research | N/A |
| Completed | A Study to Evaluate the Effect of Vitamin D Supplementation on Insulin Sensitivity and Secretion NCT00320853 | Sitaram Bhartia Institute of Science and Research | N/A |
| Completed | Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045) NCT00758069 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | The Effects of LAF237 on Gastric Function in Type 2 Diabetes NCT00952991 | Mayo Clinic | Phase 3 |
| Completed | Effectiveness and Cost-effectiveness of the Diabetes Integrated Care Breakthrough Collaborative NCT00160017 | Radboud University Medical Center | — |
| Completed | Effects of Exercise Training on Left Ventricular Function in Type 2 Diabetic Patients Post Coronary Artery Byp NCT00172536 | National Taiwan University Hospital | N/A |
| Completed | Biomarkers of Oxidative Stress in LOOK AHEAD - Ancillary to LOOK AHEAD NCT00031226 | Arizona State University | — |
| Completed | Dietary Fiber and Cardiovascular Inflammatory Markers NCT00085800 | Medical University of South Carolina | — |
| Completed | Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes NCT00071422 | Exsulin Corporation | Phase 2 |
| Completed | Genetic Markers of Coronary Heart Disease in Type 2 Diabetes NCT00078052 | Harvard School of Public Health (HSPH) | — |
| Completed | The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention) NCT00069784 | Sanofi | Phase 3 |
| Completed | VLDL and LDL Particle Types as Coronary Heart Disease Risk Factors NCT00065793 | Brigham and Women's Hospital | — |
| Completed | Weight Loss Maintenance (WLM) NCT00054925 | Duke University | N/A |
| Completed | Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide NCT00044707 | AstraZeneca | Phase 2 |
| Completed | Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 NCT00044694 | AstraZeneca | Phase 2 |
| Completed | Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes NCT00044408 | Chromaderm, Inc. | Phase 3 |
| Completed | Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes NCT00044395 | Eli Lilly and Company | Phase 3 |
| Completed | Multi-Ethnic Study of Atherosclerosis (MESA) - Ancillary Eye Study NCT00041444 | University of Wisconsin, Madison | — |
| Completed | Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus NCT00035984 | AstraZeneca | Phase 3 |
| Completed | A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose NCT00035568 | Bristol-Myers Squibb | Phase 4 |
| Completed | Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a NCT00039026 | AstraZeneca | Phase 3 |
| Completed | A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Chi NCT00035542 | Bristol-Myers Squibb | Phase 3 |
| Completed | Obese Patients With Type 2 Diabetes NCT00029848 | Sanofi | Phase 3 |
| Completed | Heavy Metals, Obesity and Cardiovascular Risk - Ancillary to Look AHEAD NCT00031213 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | VA HDL Intervention Trial (VA-HIT) Ancillary Study Data Analysis NCT00035711 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | MRI Derived Organ & Tissue Mass Changes With Weight Loss - Ancillary to Look AHEAD NCT00031200 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | Dyslipidemia and Risk of Cardiovascular Disease in Diabetic Men and Women NCT00037258 | Brigham and Women's Hospital | — |
| Completed | Prenatal Nutrition and Adult Disease NCT00024583 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | Sleep Apnea in Look AHEAD Participants - Ancillary to Look AHEAD NCT00031239 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | Epidemiology of Cardiovascular Disease in Diabetes NCT00037297 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | Mechanisms of Pro-Thrombosis in Diabetes Mellitus -- Ancillary to BARI 2D NCT00041405 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum NCT00044447 | Sanofi | Phase 3 |
| Completed | Serum Total Homocysteine and C-Reactive Protein - Ancillary to IDNT NCT00021918 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | Non-Traditional Cardiovascular Risk Factors in Type 2 Diabetes Mellitus - Ancillary to VA Study of Glycemic Co NCT00021944 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes NCT00006305 | University of Pittsburgh | Phase 3 |
| Completed | Health Effects of Liposuction in Overweight Women With Elevated Insulin Levels, Impaired Glucose Tolerance and NCT00005760 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | — |
| Completed | Acute Glycemic Effects of a Very Low Fat Diet in Type 2 Diabetes NCT00006432 | National Center for Research Resources (NCRR) | N/A |
| Completed | Education and Group Support for Diabetic Hispanics NCT00004983 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | N/A |
| Completed | Enhancing Support for Women at Risk for Heart Disease NCT00142701 | Oregon Research Institute | N/A |
| Completed | Study of the Effects of Vitamin C on Patients With Type 2 Diabetes NCT00001870 | National Center for Complementary and Integrative Health (NCCIH) | Phase 2 |
| Completed | Effects of Reiki on Painful Neuropathy and Cardiovascular Risk Factors NCT00010751 | National Center for Complementary and Integrative Health (NCCIH) | Phase 2 |
| Completed | Methods for Measuring Insulin Sensitivity NCT00001625 | National Center for Complementary and Integrative Health (NCCIH) | — |
| Completed | Diabetes, Lipoproteins and Accelerated Vascular Disease NCT00005479 | Columbia University | — |
| Completed | Diabetes Prevention Program NCT00004992 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 3 |
| Completed | Diet, Insulin Resistance, and Cardiovascular Risk NCT00005530 | University of South Carolina | — |
| Completed | Genetics of the Metabolic Syndrome in Japanese Americans NCT00005374 | University of Washington | — |
| Completed | Lifestyle Management for Women With CHD and NIDDM NCT00005441 | Oregon Research Institute | — |
| Completed | Central Obesity and Disease Risk in Japanese Americans NCT00005365 | University of Washington | — |
| Completed | Heritage Study--Genetics, Exercise and Risk Factors NCT00005137 | Washington University School of Medicine | N/A |
| Completed | Physical Activity, Hypertension, Diabetes, and Coronary Heart Disease NCT00005419 | Stanford University | — |
| Completed | Genetics of Atherosclerosis in Mexican Americans NCT00005462 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | Incidence of Diabetes and Cardiovascular Disease in Mexican Americans NCT00005205 | The University of Texas Health Science Center at San Antonio | — |
| Completed | Prospective Study of Diabetes-related Vascular Disease in Oklahoma Indians NCT00005193 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | Diabetes and Cardiovascular Risk In Mexico City (San Antonio Heart Study) NCT00005146 | The University of Texas Health Science Center at San Antonio | — |
| Completed | NNC 90-1170 Mechanism of Action: A Double-Blind, Randomized, Single-Center, Placebo-Controlled, Crossover Stud NCT00013910 | National Center for Research Resources (NCRR) | Phase 1 |
| Unknown | Identification and Therapy Efficacy of Type 2 Diabetes in Hispanic Patients NCT00004572 | National Center for Research Resources (NCRR) | — |
| Completed | An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes NCT00065312 | Eli Lilly and Company | Phase 2 |